{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:10:06Z","timestamp":1794629406334,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Duke Viral Vector Core fund"},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG057522"],"award-info":[{"award-number":["R01 AG057522"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R41 AG077992"],"award-info":[{"award-number":["R41 AG077992"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-50515-6","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:03:37Z","timestamp":1724396617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-7992","authenticated-orcid":false,"given":"Boris","family":"Kantor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rittiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dellila","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5663-7372","authenticated-orcid":false,"given":"Wendy","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-8785","authenticated-orcid":false,"given":"Ornit","family":"Chiba-Falek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"50515_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"50515_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"50515_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"50515_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0578-6","volume":"10","author":"A Conti","year":"2018","unstructured":"Conti, A. & Di Micco, R. p53 activation: a checkpoint for precision genome editing? Genome Med. 10, 66 (2018).","journal-title":"Genome Med."},{"key":"50515_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.stem.2016.01.022","volume":"18","author":"MA Mandegar","year":"2016","unstructured":"Mandegar, M. A. et al. CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs. Cell Stem Cell 18, 541\u2013553 (2016).","journal-title":"Cell Stem Cell"},{"key":"50515_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrg.2016.28","volume":"17","author":"SQ Tsai","year":"2016","unstructured":"Tsai, S. Q. & Joung, J. K. Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat. Rev. Genet. 17, 300\u2013312 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"50515_CR7","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1093\/nar\/gkt520","volume":"41","author":"D Bikard","year":"2013","unstructured":"Bikard, D. et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41, 7429\u20137437 (2013).","journal-title":"Nucleic Acids Res."},{"key":"50515_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442\u2013451 (2013).","journal-title":"Cell"},{"key":"50515_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nmeth.2598","volume":"10","author":"ML Maeder","year":"2013","unstructured":"Maeder, M. L. et al. CRISPR RNA-guided activation of endogenous human genes. Nat. Methods 10, 977\u2013979 (2013).","journal-title":"Nat. Methods"},{"key":"50515_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nbt.2889","volume":"32","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 32, 670\u2013676 (2014).","journal-title":"Nat. Biotechnol."},{"key":"50515_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173\u20131183 (2013).","journal-title":"Cell"},{"key":"50515_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2014.09.039","volume":"159","author":"ME Tanenbaum","year":"2014","unstructured":"Tanenbaum, M. E. et al. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159, 635\u2013646 (2014).","journal-title":"Cell"},{"key":"50515_CR13","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/nprot.2013.132","volume":"8","author":"MH Larson","year":"2013","unstructured":"Larson, M. H. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8, 2180\u20132196 (2013).","journal-title":"Nat. Protoc."},{"key":"50515_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583\u2013588 (2015).","journal-title":"Nature"},{"key":"50515_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnmol.2020.00148","volume":"13","author":"JE Rittiner","year":"2020","unstructured":"Rittiner, J. E. et al. Gene-editing technologies paired with viral vectors for translational research into neurodegenerative diseases. Front. Mol. Neurosci. 13, 148 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"50515_CR16","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1093\/nar\/gkw159","volume":"44","author":"A Vojta","year":"2016","unstructured":"Vojta, A. et al. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res. 44, 5615\u20135628 (2016).","journal-title":"Nucleic Acids Res."},{"key":"50515_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","volume":"167","author":"XS Liu","year":"2016","unstructured":"Liu, X. S. et al. Editing DNA methylation in the mammalian genome. Cell 167, 233\u2013247 e17 (2016).","journal-title":"Cell"},{"key":"50515_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","volume":"172","author":"XS Liu","year":"2018","unstructured":"Liu, X. S. et al. Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene. Cell 172, 979\u2013992 e6 (2018).","journal-title":"Cell"},{"key":"50515_CR19","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","volume":"26","author":"B Kantor","year":"2018","unstructured":"Kantor, B. et al. Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD. Mol. Ther. 26, 2638\u20132649 (2018).","journal-title":"Mol. Ther."},{"key":"50515_CR20","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1093\/hmg\/ddaa183","volume":"29","author":"V Chen","year":"2020","unstructured":"Chen, V. et al. The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson\u2019s disease SNCA mutations. Hum. Mol. Genet. 29, 3107\u20133121 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"50515_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-12-800149-3.00003-2","volume":"87","author":"B Kantor","year":"2014","unstructured":"Kantor, B. et al. Methods for gene transfer to the central nervous system. Adv. Genet. 87, 125\u2013197 (2014).","journal-title":"Adv. Genet."},{"key":"50515_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","volume":"5","author":"PI Ortinski","year":"2017","unstructured":"Ortinski, P. I. et al. Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR\/Cas9-mediated gene editing. Mol. Ther. Methods Clin. Dev. 5, 153\u2013164 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"50515_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-800149-3.00002-0","volume":"87","author":"B Kantor","year":"2014","unstructured":"Kantor, B. et al. Clinical applications involving CNS gene transfer. Adv. Genet. 87, 71\u2013124 (2014).","journal-title":"Adv. Genet."},{"key":"50515_CR24","doi-asserted-by":"publisher","first-page":"1035543","DOI":"10.3389\/fbioe.2022.1035543","volume":"10","author":"J Rittiner","year":"2022","unstructured":"Rittiner, J. et al. Therapeutic modulation of gene expression in the disease state: treatment strategies and approaches for the development of next-generation of the epigenetic drugs. Front. Bioeng. Biotechnol. 10, 1035543 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"50515_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"50515_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14500","volume":"8","author":"E Kim","year":"2017","unstructured":"Kim, E. et al. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat. Commun. 8, 14500 (2017).","journal-title":"Nat. Commun."},{"key":"50515_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature21059","volume":"542","author":"D Burstein","year":"2017","unstructured":"Burstein, D. et al. New CRISPR-Cas systems from uncultivated microbes. Nature 542, 237\u2013241 (2017).","journal-title":"Nature"},{"key":"50515_CR28","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","volume":"81","author":"X Xu","year":"2021","unstructured":"Xu, X. et al. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Mol. Cell 81, 4333\u20134345 e4 (2021).","journal-title":"Mol. Cell"},{"key":"50515_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04048-4","volume":"9","author":"PI Thakore","year":"2018","unstructured":"Thakore, P. I. et al. RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors. Nat. Commun. 9, 1674 (2018).","journal-title":"Nat. Commun."},{"key":"50515_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nmeth.3871","volume":"13","author":"A Chavez","year":"2016","unstructured":"Chavez, A. et al. Comparison of Cas9 activators in multiple species. Nat. Methods 13, 563\u2013567 (2016).","journal-title":"Nat. Methods"},{"key":"50515_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41556-020-00620-7","volume":"23","author":"M Nakamura","year":"2021","unstructured":"Nakamura, M. et al. CRISPR technologies for precise epigenome editing. Nat. Cell Biol. 23, 11\u201322 (2021).","journal-title":"Nat. Cell Biol."},{"key":"50515_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41592-018-0048-5","volume":"15","author":"NC Yeo","year":"2018","unstructured":"Yeo, N. C. et al. An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat. Methods 15, 611\u2013616 (2018).","journal-title":"Nat. Methods"},{"key":"50515_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fgeed.2020.00009","volume":"2","author":"CG Duke","year":"2020","unstructured":"Duke, C. G. et al. An improved CRISPR\/dCas9 interference tool for neuronal gene suppression. Front. Genome Ed. 2, 9 (2020).","journal-title":"Front. Genome Ed."},{"key":"50515_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/mt.2010.277","volume":"19","author":"B Kantor","year":"2011","unstructured":"Kantor, B. et al. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Mol. Ther. 19, 547\u2013556 (2011).","journal-title":"Mol. Ther."},{"key":"50515_CR35","doi-asserted-by":"publisher","first-page":"9993","DOI":"10.1073\/pnas.0604142103","volume":"103","author":"AP Poon","year":"2006","unstructured":"Poon, A. P., Gu, H. & Roizman, B. ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc. Natl Acad. Sci. USA 103, 9993\u20139998 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50515_CR36","doi-asserted-by":"publisher","first-page":"17234","DOI":"10.1073\/pnas.0407933101","volume":"101","author":"M Nevels","year":"2004","unstructured":"Nevels, M., Paulus, C. & Shenk, T. Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proc. Natl Acad. Sci. USA 101, 17234\u201317239 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50515_CR37","doi-asserted-by":"publisher","first-page":"18730","DOI":"10.1074\/jbc.M111.337204","volume":"287","author":"AN Richart","year":"2012","unstructured":"Richart, A. N. et al. Characterization of chromoshadow domain-mediated binding of heterochromatin protein 1alpha (HP1alpha) to histone H3. J. Biol. Chem. 287, 18730\u201318737 (2012).","journal-title":"J. Biol. Chem."},{"key":"50515_CR38","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/mt.2010.170","volume":"18","author":"PE Monahan","year":"2010","unstructured":"Monahan, P. E. et al. Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Mol. Ther. 18, 1907\u20131916 (2010).","journal-title":"Mol. Ther."},{"key":"50515_CR39","doi-asserted-by":"publisher","first-page":"18786","DOI":"10.1073\/pnas.0905859106","volume":"106","author":"B Kantor","year":"2009","unstructured":"Kantor, B. et al. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc. Natl Acad. Sci. USA 106, 18786\u201318791 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50515_CR40","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1128\/jvi.71.3.1747-1756.1997","volume":"71","author":"DJ Pereira","year":"1997","unstructured":"Pereira, D. J. & Muzyczka, N. The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter. J. Virol. 71, 1747\u20131756 (1997).","journal-title":"J. Virol."},{"key":"50515_CR41","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1128\/jvi.68.4.2632-2648.1994","volume":"68","author":"C Van Lint","year":"1994","unstructured":"Van Lint, C. et al. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 68, 2632\u20132648 (1994).","journal-title":"J. Virol."},{"key":"50515_CR42","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1093\/nar\/gki720","volume":"33","author":"V Goffin","year":"2005","unstructured":"Goffin, V. et al. Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity. Nucleic Acids Res. 33, 4285\u20134310 (2005).","journal-title":"Nucleic Acids Res."},{"key":"50515_CR43","doi-asserted-by":"crossref","unstructured":"Lee, D. H. et al. Comparison of three heterochromatin protein 1 homologs in Drosophila. J. Cell Sci. 132, jcs222729 (2019).","DOI":"10.1242\/jcs.222729"},{"key":"50515_CR44","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1128\/MCB.21.7.2555-2569.2001","volume":"21","author":"JF Smothers","year":"2001","unstructured":"Smothers, J. F. & Henikoff, S. The hinge and chromo shadow domain impart distinct targeting of HP1-like proteins. Mol. Cell Biol. 21, 2555\u20132569 (2001).","journal-title":"Mol. Cell Biol."},{"key":"50515_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/3-540-27310-7_6","volume":"38","author":"A Razin","year":"2005","unstructured":"Razin, A. & Kantor, B. DNA methylation in epigenetic control of gene expression. Prog. Mol. Subcell. Biol. 38, 151\u2013167 (2005).","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"50515_CR46","doi-asserted-by":"crossref","unstructured":"Dong, W. & Kantor, B. Lentiviral vectors for delivery of gene-editing systems based on CRISPR\/Cas: current state and perspectives. Viruses 13, 1288 (2021).","DOI":"10.3390\/v13071288"},{"key":"50515_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000316","volume":"43","author":"C Policarpi","year":"2021","unstructured":"Policarpi, C., Dabin, J. & Hackett, J. A. Epigenetic editing: dissecting chromatin function in context. Bioessays 43, e2000316 (2021).","journal-title":"Bioessays"},{"key":"50515_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel, M. et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154\u2013156 (2003).","journal-title":"Nat. Genet."},{"key":"50515_CR49","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen, J. C. et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264\u20131272 (2006).","journal-title":"N. Engl. J. Med."},{"key":"50515_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnmol.2018.00002","volume":"11","author":"P Vercruysse","year":"2018","unstructured":"Vercruysse, P. et al. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front. Mol. Neurosci. 11, 2 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"50515_CR51","doi-asserted-by":"crossref","unstructured":"Yang, A., Kantor, B. & Chiba-Falek, O. APOE: the new frontier in the development of a therapeutic target towards precision medicine in late-onset Alzheimer\u2019s. Int. J. Mol. Sci. 22, 1244 (2021).","DOI":"10.3390\/ijms22031244"},{"key":"50515_CR52","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/30764","volume":"393","author":"X Nan","year":"1998","unstructured":"Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386\u2013389 (1998).","journal-title":"Nature"},{"key":"50515_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","volume":"88","author":"X Nan","year":"1997","unstructured":"Nan, X., Campoy, F. J. & Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471\u2013481 (1997).","journal-title":"Cell"},{"key":"50515_CR54","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.1128\/MCB.18.11.6538","volume":"18","author":"B Hendrich","year":"1998","unstructured":"Hendrich, B. & Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538\u20136547 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"50515_CR55","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.modgep.2003.07.003","volume":"3","author":"B Kantor","year":"2003","unstructured":"Kantor, B. et al. Expression and localization of components of the histone deacetylases multiprotein repressory complexes in the mouse preimplantation embryo. Gene Expr. Patterns 3, 697\u2013702 (2003).","journal-title":"Gene Expr. Patterns"},{"key":"50515_CR56","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew, W. L. et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat. Methods 13, 868\u2013874 (2016).","journal-title":"Nat. Methods"},{"key":"50515_CR57","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.ymthe.2020.06.027","volume":"28","author":"AM Moreno","year":"2020","unstructured":"Moreno, A. M. et al. In situ gene therapy via AAV-CRISPR-Cas9-mediated targeted gene regulation. Mol. Ther. 28, 1931 (2020).","journal-title":"Mol. Ther."},{"key":"50515_CR58","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","volume":"171","author":"HK Liao","year":"2017","unstructured":"Liao, H. K. et al. In vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation. Cell 171, 1495\u20131507 e15 (2017).","journal-title":"Cell"},{"key":"50515_CR59","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41587-019-0387-5","volume":"38","author":"M Jost","year":"2020","unstructured":"Jost, M. et al. Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs. Nat. Biotechnol. 38, 355\u2013364 (2020).","journal-title":"Nat. Biotechnol."},{"key":"50515_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","volume":"167","author":"A Amabile","year":"2016","unstructured":"Amabile, A. et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167, 219\u2013232 e14 (2016).","journal-title":"Cell"},{"key":"50515_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20757-1","volume":"12","author":"MV Van","year":"2021","unstructured":"Van, M. V., Fujimori, T. & Bintu, L. Nanobody-mediated control of gene expression and epigenetic memory. Nat. Commun. 12, 537 (2021).","journal-title":"Nat. Commun."},{"key":"50515_CR62","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1093\/nar\/gky171","volume":"46","author":"T Mlambo","year":"2018","unstructured":"Mlambo, T. et al. Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells. Nucleic Acids Res. 46, 4456\u20134468 (2018).","journal-title":"Nucleic Acids Res."},{"key":"50515_CR63","doi-asserted-by":"crossref","unstructured":"Vijayraghavan, S. & Kantor, B. A protocol for the production of integrase-deficient lentiviral vectors for CRISPR\/Cas9-mediated gene knockout in dividing cells. J. Vis. Exp. 130, 56915 (2017).","DOI":"10.3791\/56915"},{"key":"50515_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102084","volume":"35","author":"Z Sun","year":"2024","unstructured":"Sun, Z., Kantor, B. & Chiba-Falek, O. Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies. Mol. Ther. Nucleic Acids 35, 102084 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"50515_CR65","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.stemcr.2021.01.019","volume":"16","author":"KR Babcock","year":"2021","unstructured":"Babcock, K. R. et al. Adult hippocampal neurogenesis in aging and Alzheimer\u2019s disease. Stem Cell Rep. 16, 681\u2013693 (2021).","journal-title":"Stem Cell Rep."},{"key":"50515_CR66","doi-asserted-by":"crossref","unstructured":"Li, Y. J. et al. Identification of novel genes for age-at-onset of Alzheimer\u2019s disease by combining quantitative and survival trait analyses. Alzheimers Dement. 19, 3148\u20133157 (2023).","DOI":"10.1002\/alz.12927"},{"key":"50515_CR67","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4088\/JCP.v68n0419","volume":"68","author":"KD Coon","year":"2007","unstructured":"Coon, K. D. et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer\u2019s disease. J. Clin. Psychiatry 68, 613\u2013618 (2007).","journal-title":"J. Clin. Psychiatry"},{"key":"50515_CR68","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/ddm031","volume":"16","author":"A Grupe","year":"2007","unstructured":"Grupe, A. et al. Evidence for novel susceptibility genes for late-onset Alzheimer\u2019s disease from a genome-wide association study of putative functional variants. Hum. Mol. Genet. 16, 865\u2013873 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"50515_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1477-5956-6-27","volume":"6","author":"E Ernoult","year":"2008","unstructured":"Ernoult, E., Gamelin, E. & Guette, C. Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation. Proteome Sci. 6, 27 (2008).","journal-title":"Proteome Sci."},{"key":"50515_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-1-44","volume":"1","author":"R Abraham","year":"2008","unstructured":"Abraham, R. et al. A genome-wide association study for late-onset Alzheimer\u2019s disease using DNA pooling. BMC Med. Genom. 1, 44 (2008).","journal-title":"BMC Med. Genom."},{"key":"50515_CR71","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram, L. et al. Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am. J. Hum. Genet. 83, 623\u2013632 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"50515_CR72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","volume":"84","author":"GW Beecham","year":"2009","unstructured":"Beecham, G. W. et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am. J. Hum. Genet. 84, 35\u201343 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"50515_CR73","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/ng.305","volume":"41","author":"MM Carrasquillo","year":"2009","unstructured":"Carrasquillo, M. M. et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer\u2019s disease. Nat. Genet. 41, 192\u2013198 (2009).","journal-title":"Nat. Genet."},{"key":"50515_CR74","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1088\u20131093 (2009).","journal-title":"Nat. Genet."},{"key":"50515_CR75","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"50515_CR76","doi-asserted-by":"publisher","first-page":"e6501","DOI":"10.1371\/journal.pone.0006501","volume":"4","author":"SG Potkin","year":"2009","unstructured":"Potkin, S. G. et al. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer\u2019s disease. PLoS ONE 4, e6501 (2009).","journal-title":"PLoS ONE"},{"key":"50515_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3233\/JAD-2010-1212","volume":"19","author":"EL Heinzen","year":"2010","unstructured":"Heinzen, E. L. et al. Genome-wide scan of copy number variation in late-onset Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 19, 69\u201377 (2010).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"50515_CR78","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri, S. et al. Genome-wide analysis of genetic loci associated with Alzheimer\u2019s disease. JAMA 303, 1832\u20131840 (2010).","journal-title":"JAMA"},{"key":"50515_CR79","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/mp.2011.135","volume":"17","author":"MI Kamboh","year":"2012","unstructured":"Kamboh, M. I. et al. Genome-wide association analysis of age-of-onset in Alzheimer\u2019s disease. Mol. Psychiatry 17, 1340\u20131346 (2012).","journal-title":"Mol. Psychiatry"},{"key":"50515_CR80","doi-asserted-by":"crossref","unstructured":"Gottschalk, W. K. et al. The role of upregulated APOE in Alzheimer\u2019s disease etiology. J. Alzheimer\u2019s Dis. Parkinsonism 6, 209 (2016).","DOI":"10.4172\/2161-0460.1000209"},{"key":"50515_CR81","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/nprot.2006.207","volume":"1","author":"JC Grieger","year":"2006","unstructured":"Grieger, J. C., Choi, V. W. & Samulski, R. J. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1, 1412\u20131428 (2006).","journal-title":"Nat. Protoc."},{"key":"50515_CR82","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1073\/pnas.91.10.4509","volume":"91","author":"JF Margolin","year":"1994","unstructured":"Margolin, J. F. et al. Kruppel-associated boxes are potent transcriptional repression domains. Proc. Natl Acad. Sci. USA 91, 4509\u20134513 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50515-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50515-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50515-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T19:37:48Z","timestamp":1724441868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50515-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50515"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50515-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.C.-F. and B.K. are inventors of intellectual property related to this research and Duke University filed a patent application for the technology developed in this study. CLAIRIgene has an exclusive, worldwide option agreement from Duke for the related patent portfolio for all fields of use. B.K. and O.C.-F. are Co-Founders of CLAIRIgene, LLC. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7259"}}